Clarostat Consulting Limited provides statistical consultancy services to the pharmaceutical industry. We specialise in health technology assessment (HTA) and value insight for health products. Our analyses and advice provide clear value messages, so that payers can easily decide to reimburse your medicine or device.
Our unique combination of expertise in statistics and HTA gives us both the modelling and estimation mindset required in this field, plus the specialist technical knowledge of the often sophisticated techniques needed to perform those analyses correctly.
We have over 30 years of experience of working in clinical development with global pharmaceutical companies, applying our extensive knowledge of clinical statistics and drug development in the fast-moving HTA environment. Our work has supported interactions with many HTA agencies including NICE, G-BA/IQWIG, CADTH and PBAC.
Collaboration and interaction with our clients is key. We believe in working together with you and your team towards a shared goal, combining our expertise with yours to achieve the optimal outcome. Taking time to truly understand the underlying question enables us to provide you with the best solution.